Evrofarma SA (ATH:EVROF)

Evrofarma Revenue

In the year 2025, Evrofarma had annual revenue of 49.44M EUR with 8.14% growth. Evrofarma had revenue of 24.32M in the half year ending June 30, 2025, a decrease of -5.30%.

• Revenue: 49.44M
• Revenue Growth: +5.55%
• P/S Ratio: 1.00
• Revenue / Employee: 297.84K
• Employees: 210
• Market Cap: 49.22M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	49.44M	3.72M	8.14%
Dec 31, 2024	45.72M	-3.04M	-6.24%
Dec 31, 2023	48.76M	3.38M	7.45%
Dec 31, 2022	45.38M	8.68M	23.66%
Dec 31, 2021	36.70M	2.79M	8.23%